SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
-12.57%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$168M
AUM Growth
+$168M
(+37%)
Cap. Flow
+$52.4M
Cap. Flow
% of AUM
31.22%
Top 10 Holdings %
Top 10 Hldgs %
76.92%
Holding
28
New
11
Increased
8
Reduced
2
Closed
4
Top Buys
| 1 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$13.7M |
| 2 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
$13.5M |
| 3 |
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
|
$12.8M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$11.1M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$7.77M |
Top Sells
| 1 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$29.2M |
| 2 |
QLTI
QLT Inc
QLTI
|
$11.9M |
| 3 |
CUTR
Cutera, Inc.
CUTR
|
$4.85M |
| 4 |
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
|
$458K |
| 5 |
Pacira BioSciences
PCRX
|
$51K |
Sector Composition
| 1 | Healthcare | 87.44% |